Trial finds 2 cancer drugs instead of 1 increase survival 
Scientists have discovered that using a combination of two drugs for treating pancreatic cancer greatly increases patients' chances of survival for a longer time. Clinical trials have found that 29% of patients who were given two chemotherapy drugs, gemcitabine and capecitabine, lived for at least five years after diagnosis, compared with 16% who received only one of the drugs.